CPT code 77301 represents the delivery of intensity modulated radiotherapy (IMRT), a technologically advanced form of external beam radiation therapy that sculpts radiation dose to tumor volumes while sparing adjacent healthy tissues. IMRT is widely used across cancer types—head and neck, prostate, lung, gastrointestinal, thyroid, and breast—and is a critical modality in contemporary oncologic care.

Key national payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, reimbursement benchmarks, and clinical context relevant to service delivery for IMRT. Readers will find a concise summary of what CPT code 77301 covers, typical sites of service, and the clinical scenarios where IMRT is commonly applied.

The report also provides benchmarks for billing and payment practices, notes common modifiers associated with radiation therapy billing, and summarizes policy and coding considerations that affect utilization and reimbursement nationally. Where specific input data are unavailable, the text indicates that information is not provided. This summary is intended for health plan analysts, revenue cycle leaders, and radiation oncology clinicians seeking a national-level briefing on CPT code 77301.